[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-338718-105":59,"doc-detail-338718-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","a-review-on-the-impact-of-aberrant-methylation-in-breast-cancer-diagnostic-prognostic-and-therapeutic-approaches","A Review on the Impact of Aberrant Methylation in Breast Cancer - Diagnostic, Prognostic, and Therapeutic Approaches","","Breast cancer remains a major global health burden, and its pathophysiology involves epigenetic dysregulation, particularly DNA methylation and histone modifications. This review synthesizes evidence on how these epigenetic alterations influence breast cancer prognosis, diagnostic potential, and therapeutic strategies. Promoter methylation of genes such as BRCA1, DAPK1, and RASSF1A is linked to tumor development and patient survival, while methylation states of APAF1, GSTP1, and ER relate to tumor size and grade. Histone acetylation and methylation affect gene expression, tumor progression, and therapy resistance. The review highlights methylation-targeting drugs to improve chemotherapy effectiveness and identify markers distinguishing malignant from normal tissues, while emphasizing the need for further clinical validation and large-scale trials, including combination approaches targeting histone modifications.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/a-review-on-the-impact-of-aberrant-methylation-in-breast-cancer-diagnostic-prognostic-and-therapeutic-approaches/338718/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/a-review-on-the-impact-of-aberrant-methylation-in-breast-cancer-diagnostic-prognostic-and-therapeutic-approaches/338718.png","ImageObject",300,407,{"name":92,"@type":93},"Ophelia","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-11","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",12,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"How does aberrant DNA methylation contribute to breast cancer?","Question",{"text":113,"@type":114},"It regulates gene expression without changing DNA sequence, and it is linked to breast cancer development. Promoter methylation of genes such as BRCA1, DAPK1, and RASSF1A is associated with progression and patient survival.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"Which relationship is described between methylation and clinical tumor features?",{"text":118,"@type":114},"Methylation states of APAF1, GSTP1, and ER correlate with tumor size and grade, connecting epigenetic status to clinically relevant disease characteristics.",{"name":120,"@type":111,"acceptedAnswer":121},"What is the role of histone modifications in breast cancer therapy outcomes?",{"text":122,"@type":114},"Histone acetylation and methylation control gene expression, and changes in these marks are associated with tumor advancement and resistance to therapy. The review also recommends evaluating combination therapies that target histone modifications.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},338718,1790146743,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},7971461741311,"https://ap-avatar.wpscdn.com/avatar/74000253aff267980c6?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779345379180704826","Iran. J. Biotechnol. October 2024;22(4): e3897 DOI: 10.30498/ijb.2024.447513.3897   \nReview Article   \nA Review on the Impact of Aberrant Methylation in Breast Cancer: Diagnostic, Prognostic, and Therapeutic Approaches  \nMajid Hosseini1, Saba Feghhi-Najafabadi2, Mehdi Azad3*  \n1Department of Medical Biotechnology, Biotechnology Research Center, Pasteur institute of Iran, Tehran, Iran. 2Department of Immunology, Pasteur Institute of Iran, Tehran, Iran  \n3Department of Medical Laboratory Sciences, Faculty of Allied Medicine, Qazvin University of Medical Sciences, Qazvin, Iran.  \n*Corresponding author: Mehdi Azad, Department of Medical Laboratory Sciences, Faculty of Allied Medicine, Qazvin University of Medical Sciences, Qazvin, Iran. Tel: +98-2833359501 Fax: +98-2833338034, [E-mail:](E-mail: M.azad@qums.ac.ir)[ M.azad@qums.ac.ir](E-mail: M.azad@qums.ac.ir)  \nReceived: 2024/03/29 ; Accepted: 2024/11/18  \nAbstract: Breast cancer (BC) is still a major global health concern, and a key factor in its pathophysiology is epigenetic abnormalities, specifically DNA methylation and histone modifications. This review offers a thorough examination of current research on the effects of these epigenetic changes in BC, emphasizing significant discoveries in the fields of prognosis, diagnostics, and treatment strategies. In particular, the advancement of breast cancer and patient survival have been connected to promoter methylation of genes including BRCA1, DAPK1, and RASSF1A. Furthermore, there is a correlation between tumor size and grade and the methylation state of APAF1, GSTP1, and ER. Histone modifications, such as acetylation and methylation, are essential for controlling gene expression in breast cancer. Changes in these modifications are associated with the advancement of tumors and resistance to therapy. The analysis highlights the potential of methylation-targeting medicines to improve the effectiveness of traditional chemotherapy and reveals particular methylation indicators that differentiate malignant tissues from normal ones . Further clinical validation is necessary to confirm the efficacy of DNMT and HMT inhibitors in mitigating hormone resistance and epigenetic modifications in BC, despite encouraging outcomes. Large-scale trials are necessary to validate these results, and investigating combination therapy, including those targeting histone modifications, to enhance patient outcomes is oneof the main recommendations..  \nKeywords: Biomarker, Breast cancer, DNA Methylation, Treatment  \n1. Background  \nCancer is one of the most common diseases globally, which has a massive burden on society and causes many deaths worldwide (1, 2) . In 2021, there were 2.3 million women diagnosed with breast cancer (BC) and 685,000 deaths globally. As of 2020, there were 7.8 million women alive who were diagnosed with BC in the past five years, making it the world’s most prevalent cancer (3) . Even with improvements in  \nearly diagnosis and treatment, BC continues to pose a major clinical challenge. The majority of the existing diagnostic techniques, which rely on imaging and histological analysis, can be intrusive and can fail to distinguish between benign and malignant tumors or identify cancers in their early stages. Furthermore, gene expression patterns play a major role in the molecular classification of BC, which separates it into subgroups like Luminal A (ER+/PR+/HER2-), Luminal B (ER+/  \nCopyright © 2024 The Author(s); Published by National Institute of Genetic Engineering and Biotechnology. This is an open access article, distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ([http://creativecommons.org/licenses /by-nc/4.0/](http://creativecommons.org/licenses /by-nc/4.0/)) which permits others to copy and redistribute material just in noncommercial usages, provided the original work is properly cited.  \nPR+/HER2+), HER2-positive (ER-/PR-/HER2+), Triple-negative (ER-/PR-/HER2-), and indet","cbCaidOPjQpu7hWN","https://ap.wps.com/l/cbCaidOPjQpu7hWN","pdf",1385845,13,"English","# Background\n## Breast cancer burden and diagnostic challenges\n## Molecular subtypes and treatment obstacles\n## Epigenetic abnormalities and DNA methylation\n# Epigenetic mechanisms: DNA methylation and histone modifications\n## Histone methyltransferases and interaction with DNA methylation\n## Relevance to cancer-associated gene regulation\n# Clinical and therapeutic implications\n## Methylation-targeting medicines and biomarker indicators\n## Need for validation of DNMT/HMT inhibitors and combination therapy","[{\"question\":\"How does aberrant DNA methylation contribute to breast cancer?\",\"answer\":\"It regulates gene expression without changing DNA sequence, and it is linked to breast cancer development. Promoter methylation of genes such as BRCA1, DAPK1, and RASSF1A is associated with progression and patient survival.\"},{\"question\":\"Which relationship is described between methylation and clinical tumor features?\",\"answer\":\"Methylation states of APAF1, GSTP1, and ER correlate with tumor size and grade, connecting epigenetic status to clinically relevant disease characteristics.\"},{\"question\":\"What is the role of histone modifications in breast cancer therapy outcomes?\",\"answer\":\"Histone acetylation and methylation control gene expression, and changes in these marks are associated with tumor advancement and resistance to therapy. The review also recommends evaluating combination therapies that target histone modifications.\"}]","A Review on the Impact of Aberrant Methylation in Breast Cancer - Diagnostic, Prognostic, and Therapeutic Approaches | PDF",1790025248,33,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f23a1dc421ecbe6d191ab9512bb75794.webp",983,1282,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4d6725b9ed13dd9d837b8bedd27b6619.webp",982,1280,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9f590683f0b3b52c316519f0f6353f7d.webp",981,1279,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/61ae8a7fa6e6befc082fc5004003e230.webp",980,1278]